PRESS RELEASE published on 05/17/2024 at 19:32, 1 year 7 months ago Sartorius Stedim Biotech Capital Markets: Links to presentation and webcast Sartorius Stedim Biotech presented its business strategy and goals during Capital Markets Day, reaffirming its 2024 forecast and medium-term ambitions up to 2028. Links to presentation and webcast provided for broad access Business Strategy Webcast Forecast Sartorius Stedim Biotech Capital Markets Day
BRIEF published on 05/02/2024 at 15:39, 1 year 7 months ago Sartorius Stedim Biotech Announces Share and Voting Rights Update Share Capital Voting Rights Financial News Corporate Governance Sartorius Stedim Biotech
BRIEF published on 05/02/2024 at 15:39, 1 year 7 months ago Sartorius Stedim Biotech annonce une mise à jour des actions et des droits de vote Gouvernance D'Entreprise Droit De Vote Partage Le Capital Sartorius Stedim Biotechnologie Actualités Financières
PRESS RELEASE published on 05/02/2024 at 15:34, 1 year 7 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the number of shares and voting rights comprising the issued capital as of April 30, 2024 Voting Rights Shares Sartorius Stedim Biotech SA Issued Capital French Regulatory News
PRESS RELEASE published on 05/02/2024 at 15:34, 1 year 7 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL Sartorius Stedim Biotech SA announces the total number of shares and voting rights. Regulatory information according to AMF rules Déclaration Droits De Vote Capital Social Actions Sartorius Stedim Biotech SA
BRIEF published on 04/18/2024 at 07:07, 1 year 8 months ago Sartorius Stedim Biotech dévoile ses résultats du premier trimestre 2024 Résultats Financiers Marché Global Biopharmaceutique Prise De Commandes Projections Économiques
BRIEF published on 04/18/2024 at 07:07, 1 year 8 months ago Sartorius Stedim Biotech reveals its results for the first quarter of 2024 Financial Results Biopharmaceutical Global Market Taking Orders Economic Projections
PRESS RELEASE published on 04/18/2024 at 07:02, 1 year 8 months ago Sartorius Stedim Biotech publie ses résultats non audités pour le premier trimestre 2024 Sartorius Stedim Biotech publie ses résultats non audités pour le premier trimestre 2024 avec un chiffre d'affaires en baisse de 9,4%, des prises de commandes en progression et des prévisions confirmées malgré l'incertitude mondiale Chiffre D'affaires Sartorius Stedim Biotech Prises De Commandes Résultat Trimestriel Prévisions
PRESS RELEASE published on 04/18/2024 at 07:02, 1 year 8 months ago Sartorius Stedim Biotech publishes unaudited first quarter results for 2024 Sartorius Stedim Biotech publishes unaudited first quarter results for 2024, showing sales revenue of 667 million euros and order intake up 13.9 percent. Full-year outlook confirmed amidst global uncertainties Order Intake Sartorius Stedim Biotech Sales Revenue First Quarter Results Full-year Outlook
BRIEF published on 04/02/2024 at 15:40, 1 year 8 months ago Sartorius Stedim Biotech annonce sa structure en capital et droits de vote pour Mars 2024 Droits De Vote Capital Social Actions Sartorius Stedim Biotech Transparence
Published on 12/20/2025 at 00:30, 1 day 21 hours ago Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Published on 12/19/2025 at 18:30, 2 days 3 hours ago Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 2 days 7 hours ago Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 2 days 8 hours ago Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF
Published on 12/21/2025 at 08:55, 13 hours 8 minutes ago Vantage Markets recognised for real-time threat intelligence collaboration with Trend Micro
Published on 12/20/2025 at 16:45, 1 day 5 hours ago Shanghai Electric Powers Up Iraq's Energy Future with Major 625MW Efficiency Upgrade
Published on 12/20/2025 at 10:05, 1 day 11 hours ago FITUR 2026 highlights the strong synergies between Germany and Spain
Published on 12/19/2025 at 22:03, 2 days ago EAMD: Trading resumes on the Düsseldorf Stock Exchange, lawsuit filed by minority shareholders dismissed, capital increase for investments in drone projects in the defense tech sector
Published on 12/19/2025 at 21:40, 2 days ago IMG Saxony-Anhalt: 2026 in Sight - Saxony-Anhalt Sets the Pace for Future Industries
Published on 12/19/2025 at 21:57, 2 days ago Mise à disposition du document d’enregistrement universel
Published on 12/19/2025 at 08:30, 2 days 13 hours ago Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 2 days 13 hours ago Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 2 days 15 hours ago EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 2 days 15 hours ago EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION